Sinclair Pharma (SPH)

 

SPH Share PerformanceMore

52 week high38.585 09/03/16
52 week low26.000 28/09/16
52 week change -6.500 (-16.88%)
4 week volume7,975,131 01/02/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Hardman Research: Demanding targets exceeded

RNS Number: 3509U Sinclair Pharma PLC 17 January 2017 Hardman Research: Demanding targets exceeded Demanding targets exceeded - Sinclair is a pure-play aesthetics company with a concentrated and highly competitive portfolio of differentiated injectable aesthetics products, which target unmet clinical needs for effective, high quality, longer duration, natura...

Sinclair Pharma pleased with FY 2016 performance

Sinclair Pharma is pleased with its 2016 performance, a year when it made excellent progress in its strategy to build a leadi...

Pre-Close Trading Update

RNS Number: 2924U Sinclair Pharma PLC 17 January 2017 Pre-Close Trading Update 37.8 million 12 month revenue to December 31 2016, growth of 51%* Strong performance of all brands Successful US launch of Silhouette Instalift London, 17 January 2017 Sinclair Pharma plc (AIM:SPH.L) ("Sinclair" or the "Group"), the international aesthetics company, announce...

Notification of full year trading update

RNS Number: 3584T Sinclair Pharma PLC 05 January 2017 Sinclair Pharma plc Notification of full year trading update London, 05 January 2017 Sinclair Pharma plc ( SPH.L), ("Sinclair") the international Aesthetics company, will be publishing a trading update for the year ending 31 December 2016 on 17 January 2017. For further information please contact: Sinclair...

AIM shares touched by the 'Trump effect'

Lots of AIM companies could be affected by Donald Trump's likely policies. Former AIM writer of the year Andrew Hore...

Hardman Research: Poised for a long term uplift

RNS Number: 5985O Sinclair Pharma PLC 08 November 2016 Hardman Research: Poised for a long term uplift Poised for a long term uplift: Sinclair has evolved into a pure-play aesthetics company with a concentrated and highly competitive portfolio of differentiated injectable aesthetics products. These products target unmet clinical needs for effective, high quality...

Hardman Research: Poised for a long term uplift

RNS Number: 5363O Sinclair Pharma PLC 08 November 2016 Hardman Research: Poised for a long term uplift Poised for a long term uplift: Sinclair has evolved into a pure-play aesthetics company with a concentrated and highly competitive portfolio of differentiated injectable aesthetics products. These products target unmet clinical needs for effective, high quality...

Holding(s) in Company

RNS Number: 8839M Sinclair Pharma PLC 18 October 2016 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii Sinclair Pharma Plc Sedol 3385674 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting r...

Fundamental DataMore

EPS-1.5
Dividend yield0 %

Equity Research (SPH)

hardman & co
Sinclair Pharma plc
08/11/2016
Sinclair has evolved into a pure-play aesthetics company with a concentrated and highly competitive portfolio of differentiated injectable aesthetics products. These products target unmet clinical...

Latest discussion posts More

  • More on Nestle - Sinclair link...

    Already an Acquisition Nestle Health Science on Feb. 2 said it acquired CM&D Pharma Ltd., a small U.K. company that develops foods for special medical purposes, primarily ...
    17-Oct-2016
    Ambiorix1
  • Re: Results

    Nestle seems determined to take on its rivals in the dermatology field. A few days ago, Nestle enrolled Allergan executive Paul Navarre, (president of Allergan?s international ...
    14-Oct-2016
    Ambiorix1
  • Re: Results

    ..... and the recent currency movement can surely only help. E
    13-Oct-2016
    Eaglehurst

Users' HoldingsMore

Users who hold Sinclair Pharma also hold..
LLOYDS GRP.38%
BP21%
BARCLAYS20%
VODAFONE GRP.20%
AVIVA16%

Codes & Symbols

ISINGB0033856740
SymbolsSPH, LSE:SPH, SPH.L, SPH:LN, LON:SPH, XLON:SPH